Mechanism of In vitro Pancreatic Cancer Cell Growth Inhibition by Melanoma Differentiation–Associated Gene-7/Interleukin-24 and Perillyl Alcohol
Authors:
- 14 September 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (18) , 7439-7447
Abstract
The death rate for pancreatic cancer approximates the number of new cases each year, and when diagnosed, current therapeutic regimens provide little benefit in extending patient survival. These dire statistics necessitate the development of enhanced single or combinatorial therapies to decrease the pathogenesis of this invariably fatal disease. Melanoma differentiation–associated gene-7/interleukin-24 (mda-7/IL-24) is a potent cancer gene therapeutic because of its broad-spectrum cancer-specific apoptosis-inducing properties as well as its multipronged indirect antitumor activities. However, pancreatic cancer cells show inherent resistance to mda-7/IL-24 that is caused by a block of translation of mda-7/IL-24 mRNA in these tumor cells. We now reveal that a dietary agent perillyl alcohol (POH) in combination with Ad.mda-7 efficiently reverses the mda-7/IL-24 “protein translational block” by inducing reactive oxygen species, thereby resulting in mda-7/IL-24 protein production, growth suppression, and apoptosis. Pharmacologic inhibitor and small interfering RNA studies identify xanthine oxidase as a major source of superoxide radical production causing these toxic effects. Because both POH and Ad.mda-7 are being evaluated in clinical trials, combining a dietary agent and a virally delivered therapeutic cytokine provides an innovative approach for potentially treating human pancreatic cancer. [Cancer Res 2008;68(18):7439–47]Keywords
All Related Versions
This publication has 50 references indexed in Scilit:
- Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesisMolecular Cancer Therapeutics, 2008
- Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): Novel gene therapeutic for metastatic melanomaToxicology and Applied Pharmacology, 2007
- Molecular Target-Based Therapy of Pancreatic CancerCancer Research, 2006
- Recent advances in the molecular genetics of malignant gliomas disclose targets for antitumor agent perillyl alcoholSurgical Neurology, 2006
- Perillyl Alcohol Inhibits a Calcium-Dependent Constitutive Nuclear Factor-κB PathwayCancer Research, 2005
- Glutathione Redox State Regulates Mitochondrial Reactive OxygenProductionJournal of Biological Chemistry, 2005
- Focus on pancreas cancerCancer Cell, 2002
- Cancer Chemoprevention and Therapy by MonoterpenesEnvironmental Health Perspectives, 1997
- Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a Ras-independent mechanism of actionAnti-Cancer Drugs, 1996
- Chemotherapy of pancreatic cancer with the monoterpene perillyl alcoholCancer Letters, 1995